Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience

被引:76
|
作者
Morgera, S
Scholle, C
Voss, G
Haase, M
Vargas-Hein, O
Krausch, D
Melzer, C
Rosseau, S
Zuckermann-Becker, H
Neumayer, HH
机构
[1] Humboldt Univ, Charite, Dept Nephrol, D-1086 Berlin, Germany
[2] Humboldt Univ, Charite, Dept Anesthesiol, D-1086 Berlin, Germany
[3] Humboldt Univ, Charite, Dept Cardiol, D-1086 Berlin, Germany
[4] Humboldt Univ, Charite, Dept Infect Dis, D-1086 Berlin, Germany
[5] Humboldt Univ, Charite, Dept Surg, D-1086 Berlin, Germany
来源
NEPHRON CLINICAL PRACTICE | 2004年 / 97卷 / 04期
关键词
citrate anticoagulation; continuous renal replacement therapy; metabolic complications;
D O I
10.1159/000079171
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Regional anticoagulation with trisodium citrate is an effective form of anticoagulation for continuous renal replacement therapy (CRRT) in patients at a high risk of bleeding. In a prospective, observational study we compared an established regional citrate anticoagulation protocol [Mehta R et al: Kidney Int 1990; 38: 976-981] versus a standard heparin anticoagulation protocol focusing on acid-base and electrolyte derangements as well as on cost effectiveness. Methods and Results: 209 patients were included in the study. In 37 patients, citrate was used as the sole anticoagulant, 87 patients received low-dose heparin plus citrate, and 85 patients received only heparin as anticoagulant. A customized dialysate solution was used for citrate-anticoagulated CRRT (no buffer, no calcium, reduced sodium concentration). Filter life was significantly higher during citrate anticoagulation compared to heparin anticoagulation (80.2 +/- 60 vs. 30.2 +/- 32 h; p < 0.001). No difference was found between citrate and citrate-heparin anticoagulation (p = 0.310). Metabolic alkalosis was observed in more than 50% of patients on citrate anticoagulation. Alkalosis developed within the first 72 h after initiating treatment and could be reversed in almost all cases by increasing the dialysate flow rate. Hypercalcemia was observed in 13 patients on citrate anticoagulation. Patients with impaired liver function were particularly at risk. Systemic hypocalcemia, hypernatremia, and anion gap acidosis were not observed. Citrate anticoagulation was well tolerated hemodynamically. A longer filter life during citrate anticoagulation translated into a significant cost reduction compared to standard heparin anticoagulation (p < 0.01). Conclusion: Regional anticoagulation with trisodium citrate in combination with a customized calcium-free dialysate is a safe and effective alternative to a heparin-based anticoagulation regimen. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:C131 / C136
页数:6
相关论文
共 50 条
  • [31] Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration
    Hetzel, Gerd R.
    Taskaya, Gediz
    Sucker, Christoph
    Hennersdorf, Marcus
    Grabensee, Bernd
    Schmitz, Michael
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (05) : 806 - 811
  • [32] Gender differences in acid-base metabolism during continuous venovenous hemofiltration with regional citrate anticoagulation
    Koeglberger, P.
    Klein, S. J.
    Joannidis, M.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2020, 115 (06) : 521 - 522
  • [33] Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation
    Brain, Matthew
    Anderson, Mike
    Parkes, Scott
    Fowler, Peter
    CRITICAL CARE AND RESUSCITATION, 2012, 14 (04) : 274 - 282
  • [34] The Application of Regional Citrate Anticoagulation in Protein A Immunoadsorption: A Single-Center Retrospective Cohort Study
    Muhammad, Amir
    Hu, Xueling
    Pan, Juan
    Peng, Weisheng
    Li, Xia
    Huang, Mingxia
    Luo, Zengyuan
    Jiang, Dayang
    Chen, Jinbiao
    Tang, Rong
    Xiao, Xiangcheng
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024,
  • [35] REGIONAL CITRATE ANTICOAGULATION USING SINGLE-NEEDLE HEMODIALYSIS
    MOTTET, JJ
    SAXENHOFER, H
    HORBER, FF
    DESCOEUDRES, C
    KIDNEY INTERNATIONAL, 1992, 42 (03) : 807 - 807
  • [36] Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
    Claizoni dos Santos, Thais Oliveira
    dos Santos Ferreira, Carlos Eduardo
    Pitangueira Mangueira, Cristovo Luis
    Ammirati, Adriano Luiz
    Scherer, Patricia Faria
    Doher, Marisa Petrucelli
    Matsui, Thais Nemoto
    Cardoso dos Santos, Bento Fortunato
    Pereira, Virgilio Goncalves, Jr.
    Batista, Marcelo Costa
    Martins Monte, Julio Cesar
    Pavo Santos, Oscar Fernando
    de Souza Duro, Marcelino
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
    Thais Oliveira Claizoni dos Santos
    Carlos Eduardo dos Santos Ferreira
    Cristóvão Luis Pitangueira Mangueira
    Adriano Luiz Ammirati
    Patricia Faria Scherer
    Marisa Petrucelli Doher
    Thais Nemoto Matsui
    Bento Fortunato Cardoso dos Santos
    Virgílio Gonçalves Pereira
    Marcelo Costa Batista
    Julio Cesar Martins Monte
    Oscar Fernando Pavão Santos
    Marcelino de Souza Durão
    Scientific Reports, 13
  • [38] Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Perioperative Care of Liver Transplant Recipients: A Single Center Experience
    Sponholz, Christoph
    Settmacher, Utz
    Bauer, Michael
    Kortgen, Andreas
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (01) : 8 - 15
  • [39] Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
    Rita Jacobs
    Patrick M. Honore
    Marc Diltoer
    Herbert D. Spapen
    BMC Nephrology, 21
  • [40] Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate
    Gupta, M
    Wadhwa, NK
    Bukovsky, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) : 67 - 73